Abstract | PURPOSE: CLINICAL FEATURES: A 47-yr-old female with a history of a Clagett window procedure for pulmonary aspergillosis and subsequent chronic pain presented to our institute for a window closure procedure. Preoperatively, her pain regimen included Suboxone 16 mg bid, which was continued perioperatively. Postoperatively, her course was complicated by suboptimal pain at the surgical site requiring in excess of 70 mg/24 hr of intravenous hydromorphone. Liberal addition of long-acting oral opioids was ineffective in improving pain management. Eventually, concern was raised regarding opioid receptor blockade by her long-acting Suboxone, and the decision was made to taper her Suboxone. Following this, her pain control improved dramatically and her opioid requirements were markedly reduced. By discharge, her Suboxone was discontinued and she was managed on oral hydromorphone. CONCLUSION:
|
Authors | Alexander Huang, Rita Katznelson, Marc de Perrot, Hance Clarke |
Journal | Canadian journal of anaesthesia = Journal canadien d'anesthesie
(Can J Anaesth)
Vol. 61
Issue 9
Pg. 826-31
(Sep 2014)
ISSN: 1496-8975 [Electronic] United States |
PMID | 24985936
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Buprenorphine, Naloxone Drug Combination
- Naloxone
- Buprenorphine
|
Topics |
- Buprenorphine
(therapeutic use)
- Buprenorphine, Naloxone Drug Combination
- Chronic Pain
(drug therapy)
- Female
- Humans
- Middle Aged
- Naloxone
(therapeutic use)
- Pain, Postoperative
(drug therapy)
- Pulmonary Aspergillosis
(surgery)
- Thoracic Surgical Procedures
|